Chronic Myelogenous Leukemia (cml) - Histology

Relevant Publications

ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells.

Issue Release: 2024

Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment.

Issue Release: 2024

SARS-CoV-2 and chronic myeloid leukemia: a systematic review.

Issue Release: 2024

AS1041, a novel derivative of marine natural compound Aspergiolide A, induces senescence of leukemia cells via oxidative stress-induced DNA damage and BCR-ABL degradation.

Issue Release: 2024

Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro.

Issue Release: 2024

Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.

Issue Release: 2024

[The Effect and Safety of Flumatinib in Patients with Chronic Myelogenous Leukemia Failed First-and Second-line Treatment].

Issue Release: 2024

Leukemia in India: Insights Into Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years.

Issue Release: 2024

Dasatinib-induced pleural effusions, pericardial effusion and pulmonary arterial hypertension: a case report.

Issue Release: 2024

Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater.

Issue Release: 2024

[Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].

Issue Release: 2024

\"Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells\".

Issue Release: 2024

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib.

Issue Release: 2024

Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia.

Issue Release: 2024

Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection.

Issue Release: 2024

Acute Left Main Coronary Embolization Following Transcatheter Aortic Valve Implantation.

Issue Release: 2024

[Effect of Csn-B Combined with Imatinib on Apoptosis of Chronic Myeloid Leukemia Cells through Nur77/Pim-1/Drp1 Pathway].

Issue Release: 2024

[Advances in basic and clinical research of flumatinib].

Issue Release: 2024

Bosutinib: Pediatric First Approval.

Issue Release: 2023

Interleukin-9 production by type 2 innate lymphoid cells induces Paneth cell metaplasia and small intestinal remodeling.

Issue Release: 2023

How Can Antigen Heterogeneity be Addressed?

How to Interpret LDH Assay Results?

What are Some Common Applications of Centrifugation in Histology?

How to Stay Motivated for Continuing Education?

What Techniques Are Used to Study Genetic Information in Histology?

What is the Ductal System?

What is Monoclonal?

What are the Molecular Mechanisms Behind EDS?

How Do Cells Uptake Nutrients?

Why Assess Organ Damage?

Partnered Content Networks

Relevant Topics